72061323RFA00003: Preventing HIV for Sustained Epidemic Control (PREVENT) Activity.
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Zimbabwe USAID-Harare notices from 2023.
Zimbabwe USAID-Harare offered grants of up to $88.0 million (at least $17.0 million) to the applicants described in the notice. It expected to make about 2 awards worth $88.0 million in total. Applications closed on March 22, 2023.
From the official notice on Grants.gov, last changed February 23, 2023. Checked November 7, 2026.
- Award ceiling$88.0 million
- Award floor$17.0 million
- Total funding$88.0 million
- Expected awards2
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | February 13, 2023 |
|---|---|
| Deadline | March 22, 2023 |
| Archived by Grants.gov | April 21, 2023 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligibility for this NOFO is restricted to local Zimbabwean organizations. Therefore, applications should be from qualified local, Zimbabwean entities, such as private, nonprofit organizations (or for-profit companies willing to forego profits), including private voluntary organizations,universities, research organizations, professional associations, and relevant special interest associations. See ADS 303.6 for more information on "local entity"
Is this a realistic fit?
- Past USAID Foreign Assistance for Programs Overseas awards averaged $8.7 million; this notice allows up to $88.0 million per award.
- Most of the program's money (54% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
This Activity will contribute to the overall goal of Sustained HIV epidemic control. It has two objectives: ● Objective 1: Increased uptake of person-centered HIV services, with focus on biomedical prevention ● Objective 2: Improved sustainability of the HIV response
Who has won USAID Foreign Assistance for Programs Overseas grants before
From fiscal 2021 to 2025, USAID Foreign Assistance for Programs Overseas (98.001) awarded $37 billion across 4,233 grant awards, an average of $8.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Miscellaneous Foreign Awardees | District of Columbia | 489 | $6.9 billion |
| Family Health International | North Carolina | 91 | $2.1 billion |
| Catholic Relief Services - United States Conference of Catholic Bishops | Maryland | 128 | $1.2 billion |
| Save the Children Federation, Inc. | Connecticut | 100 | $814 million |
| Research Triangle Institute | North Carolina | 33 | $756 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is 72061323RFA00003 still open?
No. It closed on March 22, 2023.
Who can apply for Preventing HIV for Sustained Epidemic Control (PREVENT) Activity.?
Zimbabwe USAID-Harare accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Preventing HIV for Sustained Epidemic Control (PREVENT) Activity.?
Closed March 22, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $88.0 million each. About $88.0 million in total across about 2 awards.
Who has won USAID Foreign Assistance for Programs Overseas grants before?
The largest recipients over five fiscal years were Miscellaneous Foreign Awardees, Family Health International, Catholic Relief Services - United States Conference of Catholic Bishops. The program made 4,233 awards worth $37 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)